IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE

IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-oncology (Charlottesville, Va.) Va.), 2017-11, Vol.19 (suppl_6), p.vi125-vi125
Hauptverfasser: Ho, Winson SC, Wang, Herui, John, Kovach, Maggio, Dominic, Heiss, John, Gilbert, Mark R, Lu, Rongze, Zhuang, Zhengping
Format: Artikel
Sprache:eng
Schlagworte:
Abstracts
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page vi125
container_issue suppl_6
container_start_page vi125
container_title Neuro-oncology (Charlottesville, Va.)
container_volume 19
creator Ho, Winson SC
Wang, Herui
John, Kovach
Maggio, Dominic
Heiss, John
Gilbert, Mark R
Lu, Rongze
Zhuang, Zhengping
description
doi_str_mv 10.1093/neuonc/nox168.513
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5692410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_5692410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1403-877cfd950cc898cb6daba4aa349616f0506b1705dc23e563d063730cfbdcef003</originalsourceid><addsrcrecordid>eNpVkdFOtDAQhYn5TfRXH8C7PoBdW7otcGNSoEoj0M1ud41XDRTQNQoG1OhD-Y6yu2ri1UxmzvlmkuM4pxhNMArIeVu_dq09b7t3zPwJxWTPOcTUJZD6jP3b9i70KfYOnP_D8ICQiynDh86nzLIlpHQCZgmfZzxSqbqSEZB5IkOppcqBugSzudJC5qNGLUad5gsBXX4GbqROQK5WIv0xqDlIQ4gROgM8SqRYiQWIl3MepgJsTuUCZiKWXIsY8FxLvcxGC4-0XEl9C24SkYNIZaHMR8EWP4sxCFMVXfNYHDv7TfE41Cff9chZXgodJXD7NE-hxVNEoO95tqkCiqz1A9-WrCrKYloUZBowzBpEESuxh2hlXVJTRirEiEeQbcrK1g1C5Mi52HGfX8unehy2L33xaJ779VPRf5iuWJu_m3Z9b-66N0NZ4E7xBoB3ANt3w9DXza8XI7MJzOwCM7vAzBgY-QLtHIAz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE</title><source>Oxford Journals - Connect here FIRST to enable access</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Ho, Winson SC ; Wang, Herui ; John, Kovach ; Maggio, Dominic ; Heiss, John ; Gilbert, Mark R ; Lu, Rongze ; Zhuang, Zhengping</creator><creatorcontrib>Ho, Winson SC ; Wang, Herui ; John, Kovach ; Maggio, Dominic ; Heiss, John ; Gilbert, Mark R ; Lu, Rongze ; Zhuang, Zhengping</creatorcontrib><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/nox168.513</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Abstracts</subject><ispartof>Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi125-vi125</ispartof><rights>The Author(s) 2017. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692410/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692410/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Ho, Winson SC</creatorcontrib><creatorcontrib>Wang, Herui</creatorcontrib><creatorcontrib>John, Kovach</creatorcontrib><creatorcontrib>Maggio, Dominic</creatorcontrib><creatorcontrib>Heiss, John</creatorcontrib><creatorcontrib>Gilbert, Mark R</creatorcontrib><creatorcontrib>Lu, Rongze</creatorcontrib><creatorcontrib>Zhuang, Zhengping</creatorcontrib><title>IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE</title><title>Neuro-oncology (Charlottesville, Va.)</title><subject>Abstracts</subject><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkdFOtDAQhYn5TfRXH8C7PoBdW7otcGNSoEoj0M1ud41XDRTQNQoG1OhD-Y6yu2ri1UxmzvlmkuM4pxhNMArIeVu_dq09b7t3zPwJxWTPOcTUJZD6jP3b9i70KfYOnP_D8ICQiynDh86nzLIlpHQCZgmfZzxSqbqSEZB5IkOppcqBugSzudJC5qNGLUad5gsBXX4GbqROQK5WIv0xqDlIQ4gROgM8SqRYiQWIl3MepgJsTuUCZiKWXIsY8FxLvcxGC4-0XEl9C24SkYNIZaHMR8EWP4sxCFMVXfNYHDv7TfE41Cff9chZXgodJXD7NE-hxVNEoO95tqkCiqz1A9-WrCrKYloUZBowzBpEESuxh2hlXVJTRirEiEeQbcrK1g1C5Mi52HGfX8unehy2L33xaJ779VPRf5iuWJu_m3Z9b-66N0NZ4E7xBoB3ANt3w9DXza8XI7MJzOwCM7vAzBgY-QLtHIAz</recordid><startdate>20171106</startdate><enddate>20171106</enddate><creator>Ho, Winson SC</creator><creator>Wang, Herui</creator><creator>John, Kovach</creator><creator>Maggio, Dominic</creator><creator>Heiss, John</creator><creator>Gilbert, Mark R</creator><creator>Lu, Rongze</creator><creator>Zhuang, Zhengping</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20171106</creationdate><title>IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE</title><author>Ho, Winson SC ; Wang, Herui ; John, Kovach ; Maggio, Dominic ; Heiss, John ; Gilbert, Mark R ; Lu, Rongze ; Zhuang, Zhengping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1403-877cfd950cc898cb6daba4aa349616f0506b1705dc23e563d063730cfbdcef003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Abstracts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ho, Winson SC</creatorcontrib><creatorcontrib>Wang, Herui</creatorcontrib><creatorcontrib>John, Kovach</creatorcontrib><creatorcontrib>Maggio, Dominic</creatorcontrib><creatorcontrib>Heiss, John</creatorcontrib><creatorcontrib>Gilbert, Mark R</creatorcontrib><creatorcontrib>Lu, Rongze</creatorcontrib><creatorcontrib>Zhuang, Zhengping</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ho, Winson SC</au><au>Wang, Herui</au><au>John, Kovach</au><au>Maggio, Dominic</au><au>Heiss, John</au><au>Gilbert, Mark R</au><au>Lu, Rongze</au><au>Zhuang, Zhengping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><date>2017-11-06</date><risdate>2017</risdate><volume>19</volume><issue>suppl_6</issue><spage>vi125</spage><epage>vi125</epage><pages>vi125-vi125</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/neuonc/nox168.513</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1522-8517
ispartof Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi125-vi125
issn 1522-8517
1523-5866
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5692410
source Oxford Journals - Connect here FIRST to enable access; PubMed Central; EZB Electronic Journals Library
subjects Abstracts
title IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A03%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IMMU-55.%20PHARMACOLOGIC%20INHIBITION%20OF%20PROTEIN%20PHOSPHATASE-2A,%20WITH%20NOVEL%20INHIBITOR%20LB-100,%20ACHIEVES%20DURABLE%20IMMUNE-MEDIATED%20ANTITUMOR%20ACTIVITY%20WHEN%20COMBINED%20WITH%20PD1%20BLOCKADE&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Ho,%20Winson%20SC&rft.date=2017-11-06&rft.volume=19&rft.issue=suppl_6&rft.spage=vi125&rft.epage=vi125&rft.pages=vi125-vi125&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/nox168.513&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_5692410%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true